Future of Digital Clinical Trials

November 17, 2021 11:00 AM - 11:45 AM

Virtual

Add to Calendar 11/17/2021 11:00:00 AM 11/17/2021 11:45:00 AM Future of Digital Clinical Trials

So much has been learned about the need to decentralize clinical trials during COVID, our panelists will discuss the overall landscape and considerations involved, including:

Join us for the virtual panel to hear:

  • Examples of how to conduct a decentralized trial
  • Regulatory considerations and current FDA guidelines
  • The expanded role of patients when trial are decentralized
MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
Virtual, Link available after registration
SVP, Scientific & Clinical Affairs, and Head, Global Center of Excellence Strategy for DCTs, ICON
Dr. Isaac R. Rodriguez-Chavez is a biomedical leader with expertise in Infectious Diseases, Viral Immunology, Viral Oncology, and Vaccinology. His experience covers the entire life cycle of medical products from basic, preclinical, interventional clinical research (phase I – IV), non-interventional clinical research, and post-marketing studies. Currently, he is a Senior Vice President, Scientific & Clinical Affairs, and Head, Global Center of Excellence Strategy for DCTs, ICON. Past positions include FDA, CDER Senior Officer for Clinical Research, Regulatory Compliance, and Policy Development modernizing clinical research through DCTs enabled by DHTs. He published numerous articles and has been an invited speaker in 100+ global conferences. He holds leadership roles at DiME, IEEE, DTRA, HCMA, Global Genes, and DIA Global Forum. He is also involved with and a member of 14 professional associations. He has a Ph.D. in Virology and Immunology; a M.S. in Microbiology; a M.H.S. in Clinical Research; and a B.S. in Biology. He completed two postdoctoral training positions in viral immunology and viral oncology combined with clinical research at the National Institute on Aging and the National Cancer Institute of the National Institutes of Health.